“The Big Four of the Millennium” was recently announced at the 61st Congress of the German Society of Gynaecology and Obstetrics. This honor identifies four individuals, whose life’s work created the standards of women’s health [more]
“The first time I felt a little awkward because I had never seen a breast with mastectomy and it was not an easy case. This woman had undergone many surgeries in her effort to make [more]
Pembrolizumab is the first drug approved by the U.S. Food and Drug Administration for use based on a biomarker (a specific genetic feature) rather than the location in the body where the tumor originated. The drug is indicated [more]
According to an analysis just published on American Cancer Society’s CA: A Cancer Journal for Clinicians, rare cancers account for almost a fifth of all new diagnoses, and up to over two thirds of all new diagnoses [more]
An ESO task force met to discuss the potential for “biosimilar” medical products in oncology, analyzing facts and debunking some myths. Some of the most used biologic drugs in oncology are going off patent in [more]
Countries struggling to broaden access to expensive new cancer drugs are being strongly warned to put cost-effectiveness first and not give in to political pressure. A team of researchers studied the impact of the NHS [more]
Rare cancers were among the topics discussed last month at the 3rd conference on European Reference Networks held in Vilnius, in Lithuania, where Dr Paolo Casali, from the Milan’s Istituto Nazionale dei Tumori illustrated the goals of the Joint [more]
When it comes to breast cancer screening with mammography, are women receiving a coherent message about the best age to start and to stop, and about frequency? A survey examined the situation in the United [more]
Cancer, genetics, “bad luck” and prevention through lifestyle: two years after their first study that tried to quantify the random mutations that accumulate during stem cell divisions in healthy cells and drive cancer in different [more]
A call to action to intervene on the many gaps in the care of patients with advanced or metastatic breast cancer (ABC/mBC), the European School of Oncology announced at the 15th St. Gallen International Breast Cancer [more]
Breast units staffed with specialist multidisciplinary teams deliver superior care and quality of life to women and men with breast cancer: this is the premise of the Manifesto on Breast Cancer Centres/Units that was discussed [more]
The Greek women sitting in the National and European parliament managed to find a prominent place in the political agenda for women with breast cancer through the establishment of the so-called “road map for treating [more]
Two comprehensive reports addressing cancer care in Europe have been published recently: «Past and current approaches to cancer care may not be sufficient for tomorrow. We face limited resources and a demand for cancer that [more]